HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joshua P Havens Selected Research
Joshua P Havens Research Topics
Disease
3
Infections
03/2023 - 01/2020
2
Substance-Related Disorders (Drug Abuse)
03/2023 - 09/2020
1
Histoplasmosis
05/2021
1
Disease Progression
05/2021
1
Weight Gain
10/2020
1
Hepatitis C
06/2020
1
Fibrosis (Cirrhosis)
06/2020
1
HIV Infections (HIV Infection)
06/2020
1
Coinfection
06/2020
Drug/Important Bio-Agent (IBA)
2
Emtricitabine (Emtriva)
FDA Link
03/2023 - 10/2020
1
tenofovir diphosphate
IBA
03/2023
1
RNA (Ribonucleic Acid)
IBA
03/2023
1
drug combination tenofovir alafenamide emtricitabine bictegravir
IBA
03/2023
1
triphosphoric acid (triphosphate)
IBA
03/2023
1
N-nitrosoiminodiacetic acid
IBA
03/2023
1
Voriconazole (Vfend)
FDA Link
Generic
05/2021
1
Antigens
IBA
05/2021
1
Itraconazole (Sporanox)
FDA Link
Generic
05/2021
1
Tenofovir (Viread)
FDA Link
10/2020
1
emtricitabine tenofovir alafenamide
IBA
10/2020
1
Protease Inhibitors (Protease Inhibitor)
IBA
09/2020
1
sofosbuvir drug combination ledipasvir
IBA
06/2020
1
Antiviral Agents (Antivirals)
IBA
06/2020
1
etravirine (TMC-125)
FDA Link
01/2020
1
Nucleosides
IBA
01/2020
1
Reverse Transcriptase Inhibitors
IBA
01/2020
Therapy/Procedure
2
Therapeutics
03/2023 - 05/2021
1
Aftercare (After-Treatment)
06/2020